Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS): A multicenter study

被引：0
|
作者：
Alshibany, Aisha
Zhou, Maggie
Warren, Emilie Ak
Ganjoo, Kristen N.
Demicco, Elizabeth
Feeney, Jordan
Lee, Jasmine
Shultz, David Benjamin
Spickard, Erik
Bui, Nam
Cardona, Kenneth
Salawu, Abdulazeez
Razak, Albiruni Ryan Abdul
机构：
[1] Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Stanford Univ, Med Ctr, Stanford, CA USA
[3] Emory Univ, Winship Canc Inst, Div Surg Oncol, Dept Surg, Atlanta, GA USA
[4] Stanford Canc Inst, Stanford, CA USA
[5] Mt Sinai Hosp, Toronto, ON, Canada
[6] Natera Inc, Austin, TX USA
[7] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[8] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[9] Stanford Univ, Stanford, CA USA
[10] Emory Univ, Winship Canc Inst, Atlanta, GA USA
[11] Univ Toronto, Univ Hlth Network, Div Med Oncol & Hematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11537
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Analysis of circulating tumor DNA in localized lung cancer for detection of molecular residual disease and personalization of adjuvant strategies.
    Chaudhuri, Aadel
    Chabon, Jacob J.
    Lovejoy, Alexander F.
    Newman, Aaron M.
    Stehr, Henning
    Azad, Tej D.
    Carter, Justin N.
    Merriott, David J.
    Liu, Chih Long
    Kurtz, David Matthew
    Dudley, Jonathan C.
    Padda, Sukhmani Kaur
    Shrager, Joseph B.
    Neal, Joel W.
    Wakelee, Heather A.
    Loo, Billy W.
    Alizadeh, Ash A.
    Diehn, Maximilian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [32] Utility of circulating tumor DNA (ctDNA) for the detection of minimal residual disease (MRD) after curative-intent therapy for patients with localized pancreatic adenocarcinoma (PDAC): A single institution series and meta-analysis.
    Yanala, Ujwal R.
    Martos, Mary P.
    Dickey, Erin M.
    Corona, Andres M.
    Ezenwajiaku, Nkiruka
    Pizzolato, Joseph F.
    Terrero, Gretel
    Hester, Caitlin A.
    Merchant, Nipun B.
    Datta, Jashodeep
    Hosein, Peter Joel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 695 - 695
  • [33] Reference Standards for the Determination of Limit of Blank (LoB) and Limit of Detection (LoD) in Tumor-Informed, ctDNA Minimal Residual Disease (MRD) Assays
    Raymond, C.
    Fransen, S.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2022, 24 (10): : S135 - S135
  • [34] Performance characteristics of a tumor-informed circulating tumor DNA (ctDNA) minimal residual disease (MRD) assay in invasive bladder cancer in clinical practice.
    Mehler, Shoshana
    Guilbeau, Seth
    Somer, Shmuel
    Reed, Kevin
    Greene, Heather
    Vaena, Daniel A.
    Grothey, Axel
    Somer, Brad
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [35] Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
    Azad, Tej D.
    Chaudhuri, Aadel A.
    Fang, Penny
    Qiao, Yawei
    Esfahani, Mohammad S.
    Chabon, Jacob J.
    Hamilton, Emily G.
    Yang, Yi D.
    Lovejoy, Alex
    Newman, Aaron M.
    Kurtz, David M.
    Jin, Michael
    Schroers-Martin, Joseph
    Stehr, Henning
    Liu, Chih Long
    Hui, Angela Bik-Yu
    Patel, Viren
    Maru, Dipen
    Lin, Steven H.
    Alizadeh, Ash A.
    Diehn, Maximilian
    [J]. GASTROENTEROLOGY, 2020, 158 (03) : 494 - +
  • [36] Tumor-informed circulating tumor DNA (TI-ctDNA) based molecular residual disease (MRD) detection and relapse risk for patients with stage II-IV melanoma in surgical remission: A single center experience
    Rhea, Logan
    Daniels, Megan
    Sabo, Roy
    Poklepovic, Andrew Stewart
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [37] A patient-specific, tumor-informed, circulating tumor DNA (ctDNA)-based minimal residual disease (MRD) assay in surgical patients with biliary tract cancer
    Song, Tianqiang
    Wu, Qiang
    Cui, Yunlong
    Li, Huikai
    Zhang, Wei
    Fang, Feng
    Xiong, Qingqing
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [38] Comparison of Circulating Tumor DNA Assays for Molecular Residual Disease Detection in Early-Stage Triple-Negative Breast Cancer
    Coakley, Maria
    Villacampa, Guillermo
    Sritharan, Prithika
    Swift, Claire
    Dunne, Kathryn
    Kilburn, Lucy
    Goddard, Katie
    Pipinikas, Christodoulos
    Rojas, Patricia
    Emmett, Warren
    Hall, Peter
    Harper-Wynne, Catherine
    Hickish, Tamas
    Macpherson, Iain
    Okines, Alicia
    Wardley, Andrew
    Wheatley, Duncan
    Waters, Simon
    Palmieri, Carlo
    Winter, Matthew
    Cutts, Rosalind J.
    Garcia-Murillas, Isaac
    Bliss, Judith
    Turner, Nicholas C.
    [J]. CLINICAL CANCER RESEARCH, 2024, 30 (04) : 895 - 903
  • [39] Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
    Semenkovich, Nicholas P.
    Szymanski, Jeffrey J.
    Earland, Noah
    Chauhan, Pradeep S.
    Pellini, Bruna
    Chaudhuri, Aadel A.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
  • [40] REAL-WORLD TISSUE-BASED CIRCULATING TUMOR DNA (CTDNA) MINIMAL RESIDUAL DISEASE (MRD) ASSAY PREDICTS OUTCOME IN LUNG CANCER PATIENTS WHO HAD CURATIVE TREATMENTS
    Oh, Youjin
    Chung, Liam Il-Young
    Lee, Soowon
    Hong, Timothy
    Kim, Leesul
    Yoon, Sung Mi
    Park, Joo Hee
    Djunadi, Trie Arni
    Chae, Young Kwang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A15 - A15
12345